[go: up one dir, main page]

BE902307A - Procede de traitement et de prevention de l'osteoporose. - Google Patents

Procede de traitement et de prevention de l'osteoporose.

Info

Publication number
BE902307A
BE902307A BE0/214928A BE214928A BE902307A BE 902307 A BE902307 A BE 902307A BE 0/214928 A BE0/214928 A BE 0/214928A BE 214928 A BE214928 A BE 214928A BE 902307 A BE902307 A BE 902307A
Authority
BE
Belgium
Prior art keywords
bone
osteoporosis
prevention
treatment
during
Prior art date
Application number
BE0/214928A
Other languages
English (en)
French (fr)
Inventor
C Anderson
L Flora
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BE902307A publication Critical patent/BE902307A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/214928A 1984-04-30 1985-04-29 Procede de traitement et de prevention de l'osteoporose. BE902307A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60553984A 1984-04-30 1984-04-30
US68454184A 1984-12-21 1984-12-21

Publications (1)

Publication Number Publication Date
BE902307A true BE902307A (fr) 1985-10-29

Family

ID=27084975

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214928A BE902307A (fr) 1984-04-30 1985-04-29 Procede de traitement et de prevention de l'osteoporose.

Country Status (5)

Country Link
AU (1) AU568433B2 (de)
BE (1) BE902307A (de)
DE (1) DE3514583A1 (de)
IT (1) IT1188163B (de)
PH (1) PH24312A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114473T1 (de) * 1984-04-30 1994-12-15 Procter & Gamble Ausrüstung für die verwendung bei der behandlung von osteoporose.
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis
DD285240A7 (de) * 1988-09-27 1990-12-12 Technisches Glas Veb K Verfahren zur herstellung eines osteoinduktiven knochenersatzmaterials
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
AU8083694A (en) * 1993-10-19 1995-05-08 Merck & Co., Inc. Combination of bisphosphonates and growth hormone secretagogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
DE3243358A1 (de) * 1982-11-24 1984-05-24 Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch Synthetisches humanes (1-38) parathormon-fragment, verfahren zu seiner herstellung und die verwendung zur behandlung der osteoporose
ATE114473T1 (de) * 1984-04-30 1994-12-15 Procter & Gamble Ausrüstung für die verwendung bei der behandlung von osteoporose.
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis

Also Published As

Publication number Publication date
AU4161985A (en) 1985-11-07
AU568433B2 (en) 1987-12-24
IT1188163B (it) 1988-01-07
DE3514583A1 (de) 1985-10-31
PH24312A (en) 1990-05-29
IT8520463A0 (it) 1985-04-24

Similar Documents

Publication Publication Date Title
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
AU6760987A (en) Method of treating alzheimer's disease
BE901915A (fr) Procede pour le traitement ou la prevention des maladies provoques par l'acether du facteur d'activation des plaquettes.
EP0261814A3 (en) Therapeutic composition and method
AU6337886A (en) Glutamine treatment of catabolic dysfunction
BE902307A (fr) Procede de traitement et de prevention de l'osteoporose.
ATE135914T1 (de) Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.
BE902308A (fr) Procede de traitement et de prevention de l'osteoporose.
BE900012A (fr) Nouveau peptide.
KR970009582B1 (en) Method for the treatment of oste oporosis and related disorders
EP0461111A4 (de) Behandlung von Osteoporosis.
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
CZ28395A3 (en) Therapeutic composition containing whey protein concentrate
HU890380D0 (en) Process for producing (mercapto-acyl)-amino acid derivatives and pharmaceutical preparatives containing these compounds
UA19335A (uk) Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу
UA19674A (uk) Композиція для обробки коhтактhих ліhз
EP0330756A3 (en) Thienotricyclics for the treatment of bronchial diseases
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
LTIP1535A (en) Method for treatment of skins and hides
IL67802A (en) Process for controlling patterns of chemical stimuli administration to biological tissue
AU7491487A (en) Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.
SU1572575A1 (ru) Уctpoйctbo для лeчehия пepeлomob mыщeлkoboгo otpoctka hижheй чeлюctи
SU1572579A1 (ru) Cпocoб лeчehия дeфopmaций пepeдheгo otдeлa ctoпы
CS260489A1 (en) Method of waste waters final treatment from technological processes of leather tanning
CS564387A1 (en) Method of ores' difficult-to-leach fine portions treatment

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20040430